← FDA Drug Approvals (Drugs@FDA)
GEMMILY
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2020-11-09
Drug application
- FDA Application #
ANDA213317- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GEMMILY
- Generic name
- NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- XIROMED
- Manufacturer
- Xiromed, LLC
- First approval
- 2020-11-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown